A Japanese health official admitted that a doctor diagnosed with tuberculosis examined over 600 patients without wearing a protective mask.
The doctor, who is in his 50s and runs a clinic in central Ito city, began displaying symptoms of the potentially lethal airborne disease in mid-August, but brushed them off as a common cold, the health authority official said.
Screening Tests for Tuberculosis
Tuberculin skin test and Interferon - Release Assays are tests used to screen for tuberculosis.
Advertisement
He continued to see patients, without wearing a face mask, until he was diagnosed with tuberculosis earlier this month.
During that time he had contact with 658 people, including family members, clinic staff and more than 600 patients, five of whom were children, the authority said.
![Tuberculosis]( "Tuberculosis")
Tuberculosis, caused by Mycobacterium tuberculosis, primarily affects the lung. It may spread to other organs.
Tuberculosis is a bacterial infection that attacks the lungs and can be transmitted by coughing or sneezing. It kills approximately a million people around the world every year, according to the World Health Organization.
The disease is found all over the planet, but is more common in the developing world, where it also has a much higher mortality rate.
Letters were being sent to all patients examined by the doctor, the health authority spokesman said, adding that the names of the clinic and the doctor were not being disclosed.
"It is only 10 to 15 percent of people who suffer actual symptoms after they are infected with tuberculosis," he said.
"It also takes two to three months before they start showing these symptoms," he said, when pressed over why the authority had not acted more quickly in alerting people to their possible infection.
The doctor has since been hospitalised for treatment.
Globally, 87 percent of those diagnosed with TB were successfully treated in 2010, the last year for which data is available on the WHO website.
Source: AFP
Tuberculosis
Tuberculosis, caused by Mycobacterium tuberculosis, primarily affects the lung. It may spread to other organs.
Advertisement
Tuberculosis is a bacterial infection that attacks the lungs and can be transmitted by coughing or sneezing. It kills approximately a million people around the world every year, according to the World Health Organization.
The disease is found all over the planet, but is more common in the developing world, where it also has a much higher mortality rate.
Letters were being sent to all patients examined by the doctor, the health authority spokesman said, adding that the names of the clinic and the doctor were not being disclosed.
"It is only 10 to 15 percent of people who suffer actual symptoms after they are infected with tuberculosis," he said.
"It also takes two to three months before they start showing these symptoms," he said, when pressed over why the authority had not acted more quickly in alerting people to their possible infection.
The doctor has since been hospitalised for treatment.
Globally, 87 percent of those diagnosed with TB were successfully treated in 2010, the last year for which data is available on the WHO website.
Source: AFP
Drug Resistance - Antibiotic Resistance
Drug resistance is often a problem in malaria, tuberculosis, HIV, sexually transmitted diseases and hospital acquired diseases. Judicious use of antibiotics can control the problem.
Advertisement
Advertisement
|
Advertisement
Recommended Reading
Latest General Health News
In India, youth must be aware of the diseases linked to cigarette smoking and tobacco consumption, causing a form of healthcare emergency.
Direct coastal access may represent a viable route to public health promotion, but the relationships of coastal living are not strongest among lower-income groups.
New research by Tinnitus UK has found that over four million gardeners are putting their hearing capacity at risk this summer without using safety protection.
Mucus plugs could be targeted to help reduce fatalities from chronic obstructive pulmonary disease.
The development of reliable curative therapies for multiple sclerosis could significantly reduce the economic burden of the disease on patients and wider society.